|
ZNF704 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.77860000061258E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.24140039861709E-10 |
| Normal-vs-Stage2 |
1.52099999994881E-06 |
| Normal-vs-Stage3 |
6.12980000092023E-09 |
| Normal-vs-Stage4 |
7.327199957885E-09 |
| Stage1-vs-Stage2 |
6.989800E-01 |
| Stage1-vs-Stage3 |
1.283980E-01 |
| Stage1-vs-Stage4 |
9.028300E-02 |
| Stage2-vs-Stage3 |
5.233400E-01 |
| Stage2-vs-Stage4 |
3.792600E-01 |
| Stage3-vs-Stage4 |
7.015200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.47229999805754E-08 |
| Normal-vs-AfricanAmerican |
5.66319999999454E-05 |
| Normal-vs-Asian |
2.63819999957171E-07 |
| Caucasian-vs-AfricanAmerican |
6.954800E-01 |
| Caucasian-vs-Asian |
7.038800E-01 |
| AfricanAmerican-vs-Asian |
5.309200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.2990000014822E-08 |
| Normal-vs-Female |
2.90160000471218E-08 |
| Male-vs-Female |
6.317200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.82840001104057E-09 |
| Normal-vs-Age(41-60Yrs) |
3.35299999987271E-08 |
| Normal-vs-Age(61-80Yrs) |
6.83809997514828E-09 |
| Normal-vs-Age(81-100Yrs) |
1.579390E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.456000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.389640E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.849400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.252200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.679000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.854800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.796400E-04 |
| Classical-VS-Follicular |
6.572800E-01 |
| Classical-VS-Other |
2.241000E-01 |
| Classical-VS-Normal |
1.8457999995114E-07 |
| Tall-VS-Follicular |
1.700030E-02 |
| Tall-VS-Other |
7.792800E-01 |
| Tall-VS-Normal |
1.59099955432396E-10 |
| Follicular-VS-Other |
2.523000E-01 |
| Follicular-VS-Normal |
2.34379999963785E-07 |
| Other-VS-Normal |
1.58247999999528E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.12589999837709E-08 |
| Normal-vs-N1 |
1.10840000511203E-08 |
| N0-vs-N1 |
1.861850E-01 |
|
|
